BR9106744A - Processo para induzir diferenciacao celular,preparacao farmaceutica,composicao e uso de um composto - Google Patents

Processo para induzir diferenciacao celular,preparacao farmaceutica,composicao e uso de um composto

Info

Publication number
BR9106744A
BR9106744A BR919106744A BR9106744A BR9106744A BR 9106744 A BR9106744 A BR 9106744A BR 919106744 A BR919106744 A BR 919106744A BR 9106744 A BR9106744 A BR 9106744A BR 9106744 A BR9106744 A BR 9106744A
Authority
BR
Brazil
Prior art keywords
compound
composition
pharmaceutical preparation
cellular differentiation
inducing cellular
Prior art date
Application number
BR919106744A
Other languages
English (en)
Inventor
Yusuf A Hannun
Roberto M Bell
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of BR9106744A publication Critical patent/BR9106744A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR919106744A 1990-08-13 1991-08-13 Processo para induzir diferenciacao celular,preparacao farmaceutica,composicao e uso de um composto BR9106744A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56697890A 1990-08-13 1990-08-13
PCT/US1991/005743 WO1992003129A1 (en) 1990-08-13 1991-08-13 Methods for inducing cell differentiation using ceramides

Publications (1)

Publication Number Publication Date
BR9106744A true BR9106744A (pt) 1993-07-20

Family

ID=24265249

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106744A BR9106744A (pt) 1990-08-13 1991-08-13 Processo para induzir diferenciacao celular,preparacao farmaceutica,composicao e uso de um composto

Country Status (8)

Country Link
EP (1) EP0543922A4 (pt)
JP (1) JPH05508863A (pt)
KR (1) KR970004038B1 (pt)
AU (1) AU653363B2 (pt)
BR (1) BR9106744A (pt)
CA (1) CA2089001A1 (pt)
HU (1) HUT65932A (pt)
WO (1) WO1992003129A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2690343B1 (fr) * 1992-04-28 1995-09-01 Inocosm Laboratoires Composition anti-radicalaire et anti-lipoperoxydante.
CA2182485A1 (en) * 1994-02-02 1995-08-10 Yong Wei Pharmaceutically active compounds and liposomes, and methods of use thereof
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
DK0778263T3 (da) * 1994-08-22 2002-04-22 Mitsubishi Pharma Corp Benzenforbindelser og farmaceutisk anvendelse af disse
FR2747308B1 (fr) * 1996-04-11 1998-07-10 Shrivastava Ravi Association de margousier, de (-) hydroxycitrate et de ceramides et compositions les renfermant
KR19980034991A (ko) 1996-11-11 1998-08-05 안용찬 비천연세라미드 관련화합물 및 이를 함유하는 피부외용제
DE602004020316D1 (de) 2003-01-20 2009-05-14 Tno Die verwendung von sphingolipiden zur senkung der cholesterin- und triglyzeridspiegel im plasma.
NL1022443C2 (nl) 2003-01-20 2004-07-22 Tno Sphingolipiden voor verbetering van de samenstelling van de darmflora.
EP1618876A1 (en) * 2004-07-19 2006-01-25 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Use of sphingolipids for prevention and treatment of atherosclerosis
ATE539741T1 (de) * 2004-11-30 2012-01-15 Tno Sphingolipide bei der behandlung und prävention von hepatischer steatose
EP1661562A1 (en) * 2004-11-30 2006-05-31 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Sphingolipids in treatment and prevention of steatosis
JP2016188180A (ja) * 2015-03-30 2016-11-04 株式会社東洋新薬 特定成分含有組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
JP2588729B2 (ja) * 1987-10-05 1997-03-12 塩野義製薬株式会社 スフィンゴシン誘導体

Also Published As

Publication number Publication date
CA2089001A1 (en) 1992-02-14
AU653363B2 (en) 1994-09-29
EP0543922A4 (en) 1993-07-28
HU9300375D0 (en) 1993-05-28
AU8496091A (en) 1992-03-17
EP0543922A1 (en) 1993-06-02
KR970004038B1 (ko) 1997-03-24
JPH05508863A (ja) 1993-12-09
WO1992003129A1 (en) 1992-03-05
HUT65932A (en) 1994-07-28

Similar Documents

Publication Publication Date Title
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR1100240A (pt) Composto; processo para a preparação de um composto; composição farmacêutica; e uso de um composto
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
BR9505107A (pt) Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso
BR9100435A (pt) Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica
BR9004852A (pt) Composto,processo para sua preparacao,sua aplicacao e composicao farmaceutica
BR1100979A (pt) Derivado de carboidrato, processo para preparar um derivado de carboidrato, composição farmacêutica de carboidrato e uso de derivado de carboidrato
BR8906988A (pt) Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico
AR231987A1 (es) Procedimiento para preparar derivados farmaceuticos de pirrolo-2,1-c 1,4 tiazepin-1,5-diona y compuesto intermediario para uso exclusivo en el mismo
BR9404809A (pt) Composto, uso, formulação farmacêutica e processo para preparar um composto
BR8906576A (pt) Processo para a preparacao de um derivado de pirimidina,mistura herbicida e composicao herbicida
BR9000216A (pt) Composicao de polimero de organossilicio,processo para sua producao e uso da mesma
BR9106744A (pt) Processo para induzir diferenciacao celular,preparacao farmaceutica,composicao e uso de um composto
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
BR9106118A (pt) Antraquinona substituida,composicao famaceutica e processo para inibir quinase c de proteina e,uso de um composto
PT95672A (pt) Processo para a preparacao de composicoes ceramicas
BR9005793A (pt) Composicao de fluoreto estanoso aquoso estabilizada e processo para preparacao da mesma
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR9505132A (pt) Composto processo para a preparaçao do mesmo seu uso composiçao farmacêutica e processo para a produçao da mesma
BR9004746A (pt) Composicao;processo para preparacao de borracha;composicao de borracha
MX9101516A (es) Derivados de 1,2,5,6-tetrahidropiridin 3-cetoxima y-3-aldoxina y procedimiento para su preparacion
MX9100742A (es) Composicion farmaceutica y procedimiento para su preparacion
BR9103479A (pt) Composto,estereoisomero,composicao farmaceutica e processo para a preparacao de um composto